U.S. flag An official website of the United States government
  1. Home
  2. Drug Databases
  3. Drug Shortages

FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Report a Drug Shortage | FAQ | Background Info | Get Email Alerts | Download Current Drug Shortages | Contact Us

Start Over | Back to Previous Screen

Atropine Sulfate Injection
Status: Currently in Shortage
»Date first posted: 01/01/2012
»Therapeutic Categories: Anesthesia; Neurology; Pediatric

Expand all

Accord Healthcare Inc. (Revised 02/05/2024)

Company Contact Information:
866-941-7875, option 2

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Injection, .4 mg/1 mL (NDC 16729-525-08) Unavailable, Timelines not Available at this time Shortage duration not available. Requirements related to complying with good manufacturing practices
Injection, .4 mg/1 mL (NDC 16729-512-43) Unavailable, Timelines not Available at this time Shortage duration not available. Requirements related to complying with good manufacturing practices
Injection, 1 mg/1 mL (NDC 16729-526-08) Unavailable, Timelines not Available at this time Shortage duration not available. Requirements related to complying with good manufacturing practices
Injection, .05 mg/1 mL (NDC 16729-483-03) Unavailable, Timelines not Available at this time Shortage duration not available. Requirements related to complying with good manufacturing practices
Injection, .1 mg/1 mL (NDC 16729-484-45) Inventory on hold pending further assessment, Timelines not Available at this time Inventory on hold pending further assessment Requirements related to complying with good manufacturing practices
Injection, .1 mg/1 mL (NDC 16729-484-90) Unavailable, Timelines not Available at this time Shortage duration not available. Requirements related to complying with good manufacturing practices

American Regent, Inc. (Reverified 02/01/2024)

Company Contact Information:
800-645-1706

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Injection, 1 mg/1 mL (NDC 0517-1001-25) Available old NDC 0517-1010-25
Injection, .4 mg/1 mL (NDC 0517-1004-25) Available old NDC 0517-0401-25

Amphastar Pharmaceuticals, Inc. (Reverified 02/08/2024)

Company Contact Information:
800-423-4136

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Injection, .1 mg/1 mL (NDC 76329-3340-1) Available

Fresenius Kabi USA, LLC (Reverified 02/01/2024)

Company Contact Information:
888-386-1300

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Injection, .4 mg/1 mL (NDC 63323-580-20) Available Check wholesalers for inventory

Hikma Pharmaceuticals USA, Inc. (Revised 01/23/2024)

Company Contact Information:
800-631-2174

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Atropine Sulfate Injection, USP, Injection, 0.4 mg/1 mL (NDC 0641-6251-10) This presentation is temporarily on backorder. Additional lots will be available in the March - Aprill 2024 timeframe. Product will be made available as it is released. Demand increase for the drug

Hospira, Inc., a Pfizer Company (Reverified 02/09/2024)

Company Contact Information:
844-646-4398

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Atropine Sulfate, Injection, .1 mg/1 mL (NDC 0409-1630-10) Next Delivery: February 2024; Estimated Recovery: TBD Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay

Dear Customer Letter: Emergency Syringe Availability Update

Other
Atropine Sulfate, Injection, .05 mg/1 mL (NDC 0409-9630-05) Available

Dear Customer Letter: Emergency Syringe Availability Update

Atropine Sulfate, Injection, .1 mg/1 mL (NDC 0409-4910-34) Limited Supply Available. Next Delivery: September 2024; Estimated Recovery: TBD Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay

Dear Customer Letter: Inventory Management Update for Pfizer Hospital Rocky Mount Products dated 8-24-2023 (hyperlink)

Demand increase for the drug
Atropine Sulfate, Injection, .1 mg/1 mL (NDC 0409-4911-34) Next Delivery: June 2024; Estimated Recovery: TBD Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay

Dear Customer Letter: Emergency Syringe Availability Update

Demand increase for the drug
Injection, 0.1 mg/mL, 10 mL (NDC 0409-4911-11) Next Delivery: June 2024; Estimated Recovery: TBD Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay

Dear Customer Letter: Emergency Syringe Availability Update

Demand increase for the drug

Medefil, Inc. (Revised 01/15/2024)

Company Contact Information:
630-682-4600

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Atropine Sulfate, Injection, .1 mg/1 mL (NDC 64253-400-91) Available
Back to Top